Comment
. 2011 Mar 10;364(10):974-5; author reply 976.
doi: 10.1056/NEJMc1100105.
Frequent versus standard hemodialysis
- PMID: 21388320
- DOI: 10.1056/NEJMc1100105
Item in Clipboard
Comment
Frequent versus standard hemodialysis
N Engl J Med.
.
No abstract available
Comment on
-
In-center hemodialysis six times per week versus three times per week.N Engl J Med. 2010 Dec 9;363(24):2287-300. doi: 10.1056/NEJMoa1001593. Epub 2010 Nov 20. N Engl J Med. 2010. PMID: 21091062 Free PMC article. Clinical Trial.
Similar articles
-
How should hyperphosphatemia be managed in dialysis patients?Semin Dial. 2002 Sep-Oct;15(5):315-28. doi: 10.1046/j.1525-139x.2002.00077_1.x. Semin Dial. 2002. PMID: 12358631 Review. No abstract available.
-
Review of available intravenous iron preparations in hemodialysis.CANNT J. 2013 Apr-Jun;23(2):51-4; quiz 55-6. CANNT J. 2013. PMID: 24069699 No abstract available.
-
[Treatment of anemia in patients with chronic renal disease: is it time for self-criticism?].G Ital Nefrol. 2007 Jul-Aug;24(4):285. G Ital Nefrol. 2007. PMID: 17659497 Italian. No abstract available.
-
Iron supplementation therapy in end-stage renal disease patients on maintenance hemodialysis.Cardiovasc Hematol Disord Drug Targets. 2013 Dec;13(3):237-42. doi: 10.2174/1871529x1303140129155609. Cardiovasc Hematol Disord Drug Targets. 2013. PMID: 24479720
-
[Methods of correcting hyperphosphatemia in chronic renal failure and in dialysis (review)].Ter Arkh. 1997;69(12):63-7. Ter Arkh. 1997. PMID: 9503540 Review. Russian. No abstract available.
Cited by
-
Short, frequent, 5-days-per-week, in-center hemodialysis versus 3-days-per week treatment: a randomized crossover pilot trial through the Midwest Pediatric Nephrology Consortium.Pediatr Nephrol. 2017 Aug;32(8):1423-1432. doi: 10.1007/s00467-017-3656-x. Epub 2017 Apr 8. Pediatr Nephrol. 2017. PMID: 28389745 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
